Intralipid Emulsion
Product Images NDC 0338-0519

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Int0c 0000 01)

Chemical structure of the active ingredient in Intralipid, showing a triglyceride molecule with a glycerol backbone and three fatty acid chains represented by R groups, typical of lipid emulsions.*

FDA Label Image

Figure (Int0c 0000 02)

Chemical structure of the active ingredient in Intralipid 20 g/100mL by Baxter Healthcare CORP. The diagram depicts the molecular components and bonds of the lipid emulsion's chemical composition.*

FDA Label Image

Figure (Int0c 0000 03)

Chemical structures of five fatty acids: linoleic acid, oleic acid, palmitic acid, alpha-linolenic acid, and stearic acid, each shown with their molecular formula (C and H counts) and structural diagrams of atoms and bonds.*

FDA Label Image

Figure (Int0c 0000 04)

Chemical structure of the active ingredient in Intralipid 20 g/100 mL as depicted in the image showing a molecular diagram with functional groups and bonds.*

FDA Label Image

Figure (Int0c 0000 05)

Chemical structure diagram of the active ingredient in Intralipid 20 g/100mL, showing molecular bonds and constituent groups.*

FDA Label Image

Figure (Int0c 0000 06)

Chemical structure diagram showing Phosphatidylcholine and Phosphatidylethanolamine molecules. Each structure depicts the molecular arrangement with carbon, hydrogen, oxygen, nitrogen atoms, and phosphate groups labeled as part of the two phospholipids.*

FDA Label Image

Figure (Int0c 0000 07)

Chemical structure of the active ingredient shown in the image, depicting a molecular arrangement with multiple hydroxyl groups (CH2OH, HOCH, CH2OH) connected by carbon atoms.*

FDA Label Image

Figure 1 (Int0c 0000 08)

A cumulative incidence function plot comparing Intralipid and 4-Oil Mixed Lipid over 84 study days. The graph shows the number of subjects with events and those censored for each group, along with patients at risk over time. Data points include censored subjects marked for both treatments, with error bars indicating variability.*

FDA Label Image

Figure (Int0c 0000 09)

An illustration showing a rectangular IV bag with three ports labeled A, M, and B at the bottom. The ports each have distinct connector symbols, indicating different types of access or connection points for intravenous use.*

FDA Label Image

Figure (Int0c 0000 10)

An instructional illustration showing a person holding a rectangular bag with two ports at the bottom, labeled A and B. The image depicts the hands positioned to manipulate or prepare the bag, suggesting a step in the handling or administration process of the product.*

FDA Label Image

Figure (Int0c 0000 11)

An instructional illustration showing hands performing a step to prepare or open a container, possibly related to administration or handling of a pharmaceutical product like Intralipid. One hand holds the container while the other appears to twist or remove a cap or stopper at the top.*

FDA Label Image

Figure (Int0c 0000 12)

An instructional black-and-white illustration showing a person using their hands to connect or adjust a tubing set, likely related to the administration of Intralipid infusion. The image focuses on the hands interacting with a connector or valve on the tubing, demonstrating a procedural step.*

FDA Label Image

Figure (Int0c 0000 13)

An illustration showing an intravenous (IV) bag setup with two connectors at the bottom, designed for fluid administration. The image appears to represent the container and tubing connection for a parenteral nutrition or infusion product.*

FDA Label Image

20 Pbp (Int0c 0000 14)

Label for Intralipid 20%, a 20% intravenous fat emulsion, in a 1000 mL pharmacy bulk package. The label specifies that it is not for direct infusion and is for intravenous use only. The product is labeled by Baxter Healthcare CORP with NDC 0338-0519.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.